Maravai LifeSciences Holdings, Inc.
MRVI
$3.51
$0.072.04%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 35.45% | -32.21% | -14.53% | 73.07% | -891.66% |
| Total Depreciation and Amortization | 0.37% | 3.19% | 2.64% | 3.47% | -3.49% |
| Total Amortization of Deferred Charges | 2.05% | -15.18% | -29.94% | -12.73% | 1.34% |
| Total Other Non-Cash Items | -182.62% | 4,154.58% | -104.83% | -93.19% | 1,516.07% |
| Change in Net Operating Assets | 321.63% | -79.20% | 154.82% | -535.58% | -62.74% |
| Cash from Operations | -47.59% | -9.32% | 35.85% | -211.43% | -24.65% |
| Capital Expenditure | -1.81% | 45.10% | 10.50% | 31.92% | 10.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 98.06% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -20.04% | 349.46% | -110.92% |
| Cash from Investing | 9.58% | 86.01% | -369.05% | 44.96% | -44.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.84% | -0.26% | 99.33% | -15,064.01% | -0.80% |
| Issuance of Common Stock | 753.85% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -686.05% | -3,068.42% | 32.14% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | 122.74% | -357.54% | 33.11% |
| Cash from Financing | -437.74% | 68.69% | 97.93% | -29,295.18% | 254.82% |
| Foreign Exchange rate Adjustments | 92.79% | -252.05% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.86% | 59.44% | 85.40% | -5,229.52% | -56.57% |